Athira Pharma, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Athira Pharma, Inc. Share Price Chart

$0.00$0.00

Athira Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $-2.52	Revenue (TTM) -$100.90M	Return On Equity (TTM) -216.19%
Profit Margin 96.07%	Debt to Equity 0.29	Quarterly Earnings Growth YoY N/A

About Athira Pharma, Inc.

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.

Athira Pharma, Inc. Historical Returns

Month	Open	Close	Change %

ATHA Share Price FAQs

What is Athira Pharma, Inc. share price today?

Athira Pharma, Inc. share price today is $0.00 as on August 9, 2026 at 4:15 pm IST.

What is the 52 week high and 52 week low of Athira Pharma, Inc. stock?

52 week high/low data for Athira Pharma, Inc. is currently unavailable.

Can I buy ATHA shares in India?

Yes. You can buy ATHA in India by opening an international trading account.